Clearmind Medicine (CMND) Competitors $1.00 -0.05 (-4.76%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.99 -0.01 (-0.80%) As of 05/21/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. LPTX, SNYR, GLYC, COCP, CING, LPCN, MBRX, INAB, GOVX, and UPXIShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include Leap Therapeutics (LPTX), Synergy CHC Corp. (Uplisting) (SNYR), GlycoMimetics (GLYC), Cocrystal Pharma (COCP), Cingulate (CING), Lipocine (LPCN), Moleculin Biotech (MBRX), IN8bio (INAB), GeoVax Labs (GOVX), and Upexi (UPXI). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Leap Therapeutics Synergy CHC Corp. (Uplisting) GlycoMimetics Cocrystal Pharma Cingulate Lipocine Moleculin Biotech IN8bio GeoVax Labs Upexi Clearmind Medicine (NASDAQ:CMND) and Leap Therapeutics (NASDAQ:LPTX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, community ranking, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Does the MarketBeat Community believe in CMND or LPTX? Leap Therapeutics received 294 more outperform votes than Clearmind Medicine when rated by MarketBeat users. CompanyUnderperformOutperformClearmind MedicineN/AN/ALeap TherapeuticsOutperform Votes29468.37% Underperform Votes13631.63% Does the media refer more to CMND or LPTX? In the previous week, Leap Therapeutics had 6 more articles in the media than Clearmind Medicine. MarketBeat recorded 7 mentions for Leap Therapeutics and 1 mentions for Clearmind Medicine. Leap Therapeutics' average media sentiment score of 1.01 beat Clearmind Medicine's score of 0.00 indicating that Leap Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearmind Medicine 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Leap Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, CMND or LPTX? Clearmind Medicine is trading at a lower price-to-earnings ratio than Leap Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearmind MedicineN/AN/A-$5.26M-$1.22-0.82Leap TherapeuticsN/AN/A-$81.41M-$1.70-0.21 Do insiders and institutionals hold more shares of CMND or LPTX? 96.1% of Clearmind Medicine shares are held by institutional investors. Comparatively, 30.5% of Leap Therapeutics shares are held by institutional investors. 5.4% of Leap Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts rate CMND or LPTX? Leap Therapeutics has a consensus target price of $4.92, indicating a potential upside of 1,260.45%. Given Leap Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Leap Therapeutics is more favorable than Clearmind Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Leap Therapeutics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is CMND or LPTX more profitable? Leap Therapeutics' return on equity of -116.24% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Clearmind MedicineN/A -129.21% -61.15% Leap Therapeutics N/A -116.24%-93.18% Which has more risk and volatility, CMND or LPTX? Clearmind Medicine has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Leap Therapeutics has a beta of -0.17, indicating that its stock price is 117% less volatile than the S&P 500. SummaryLeap Therapeutics beats Clearmind Medicine on 9 of the 14 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.27M$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E Ratio-0.538.9226.8419.71Price / SalesN/A253.80392.34117.39Price / CashN/A65.8538.2534.62Price / Book1.376.466.794.50Net Income-$5.26M$143.98M$3.23B$248.18M7 Day Performance3.09%2.03%1.53%0.20%1 Month PerformanceN/A4.11%10.06%12.37%1 Year Performance-13.79%-2.87%16.72%7.04% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine0.1303 of 5 stars$1.00-4.8%N/A-16.7%$4.27MN/A-0.53N/ALPTXLeap Therapeutics2.4352 of 5 stars$0.40+6.6%$4.92+1,129.2%-85.6%$16.58MN/A-0.2140Positive NewsSNYRSynergy CHC Corp. (Uplisting)2.5636 of 5 stars$1.89+3.1%$10.00+430.2%N/A$16.51M$34.83M0.0040Trending NewsEarnings ReportAnalyst RevisionGLYCGlycoMimetics1.8807 of 5 stars$0.25-1.5%N/A-9.9%$16.32M$10,000.00-0.4350Earnings ReportCOCPCocrystal Pharma3.1494 of 5 stars$1.54-1.3%$7.00+353.4%-24.7%$15.70MN/A-0.8310Positive NewsEarnings ReportAnalyst RevisionCINGCingulate2.3095 of 5 stars$3.91-1.8%$30.67+684.3%+301.2%$15.41MN/A-0.4620News CoverageAnalyst ForecastAnalyst RevisionLPCNLipocine1.5258 of 5 stars$2.87-1.7%$10.00+248.4%-44.6%$15.35M$11.20M-3.7810MBRXMoleculin Biotech1.954 of 5 stars$1.07-0.9%$6.00+460.7%-80.4%$14.98MN/A0.0020INABIN8bio3.1997 of 5 stars$0.16-1.8%$6.00+3,650.0%-87.5%$14.52MN/A-0.2120GOVXGeoVax Labs2.158 of 5 stars$0.94+1.6%$11.10+1,080.9%-39.1%$14.28M$5.59M-0.2610UPXIUpexi0.7667 of 5 stars$10.01-5.9%N/A+36.0%$14.27M$18.63M0.00130Earnings Report Related Companies and Tools Related Companies LPTX Competitors SNYR Competitors GLYC Competitors COCP Competitors CING Competitors LPCN Competitors MBRX Competitors INAB Competitors GOVX Competitors UPXI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMND Stock Free CMND Stock Alerts